Return to the full list of Biomarkers
Electroencephalography (EEG) (during memory tasks)
Method of Measurement (Pre-analytical Tools)
Imaging
Biomarker Measured
Cell signaling
Use
Susceptibility/risk
Stage of Development
Clinical trials
Active vs Completed Trials
Active
Aim/Results
Examine if EEG can precisely explore cognitive processes in healthy subjects, with a particular interest in episodic and working memory functions that are usually altered in both AD and Mild Cognitive Impairment (MCI) as well as to better understand underlying neural mechanisms involved in these processes.
Target Population/ Population Being Studied
Healthy volunteers
Length of Current Trial
7 days
Number of Trial Participants
20
Estimated Trial Completion
December 2020
What is Required from Patients
wearing noninvasive EEG cap for the in clinic visit
What is Required from the Health System
EEG, EEG technician
Sponsor
University Hospital, Lille
“Neurophysiological Correlates of Cognitive Tasks in Healthy Volunteers -WP3 P003 (PharmacogWP3).” ClinicalTrials.gov. Accessed October 10, 2019.
https://clinicaltrials.gov/ct2/show/NCT02899403?term=biomarker&recrs=abdf&cond=Alzheimer+Disease&draw=11&rank=98